The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps you find those companies with a strong foundation that are best positioned to capitalize on future success.
Here are today's top-performing health care Small-Cap Stars as of noon on the east coast:
Horizon Pharma Inc. (HZNP)
Horizon Pharma Inc. gained 3.97% to $10.08 in morning trading today. Volume reached 853,716 by noon. The stock's average daily volume is 2,500,277 shares. Horizon Pharma Inc. has a 52-week high of $18.30 and a 52-week low of $2.11, and its 50-day SMA and 200-day SMA are $13.23 and $11.30 respectively.
Horizon Pharma Inc is a specialty pharmaceutical company. It has developed and is commercializing DUEXIS, VIMOVO and RAYOS/LODOTRA, each of which targets unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Ampio Pharmaceuticals Inc. (AMPE)
Ampio Pharmaceuticals Inc. gained 3.32% to $7.38 in morning trading today. Volume reached 286,978 by noon. The stock's average daily volume is 597,588 shares. Ampio Pharmaceuticals Inc. has a 52-week high of $10.86 and a 52-week low of $5.07, and its 50-day SMA and 200-day SMA are $7.12 and $7.32 respectively.
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, engaged in developing innovative, proprietary pharmaceutical drugs and diagnostic products to identify, treat and prevent human diseases including metabolic disorders, cancer etc.
Erba Diagnostics (ERB)
Erba Diagnostics gained 3.25% to $2.86 in morning trading today. Volume reached 18,470 by noon. The stock's average daily volume is 63,005 shares. Erba Diagnostics has a 52-week high of $4.13 and a 52-week low of $0.77, its P/E ratio is 114.6, and its 50-day SMA and 200-day SMA are $2.14 and $2.29 respectively.
ERBA Diagnostics Inc develop, manufacture and market diagnostic test kits, and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes and infectious diseases.
Raptor Pharmaceutical Corp. (RPTP)
Raptor Pharmaceutical Corp. gained 3.02% to $11.26 in morning trading today. Volume reached 303,833 by noon. The stock's average daily volume is 674,260 shares. Raptor Pharmaceutical Corp. has a 52-week high of $17.72 and a 52-week low of $7.12, and its 50-day SMA and 200-day SMA are $10.18 and $11.75 respectively.
Raptor Pharmaceutical Corp is a biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases.
Idera Pharmaceuticals Inc. (IDRA)
Idera Pharmaceuticals Inc. gained 2.37% to $2.59 in morning trading today. Volume reached 294,094 by noon. The stock's average daily volume is 1,115,643 shares. Idera Pharmaceuticals Inc. has a 52-week high of $6.87 and a 52-week low of $1.52, and its 50-day SMA and 200-day SMA are $2.83 and $3.48 respectively.
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
There's no crystal ball that will tell you what the outcome of this or that clinical trial is going to be. Even if there were, the one astonishingly wealthy person who owns it probably wouldn't share. But that doesn't mean that investing in the right small-cap health care companies can't pay dividends in the long term. While the future of a company's lead therapy may not be certain, most of its present fundamentals are. And while investing in the small-cap biotech market will always be hit-or-miss, investing in solidly built players should help boost that batting average.
Our Small-Cap Stars system uses a complex statistical regression to isolate those fundamental factors that previous success stories had in common and then identifies those small caps that are the most similar to that profile in the present.
For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most indicative of a small-cap company's potential for success.
All data provided by QuoteMedia and was accurate as of 12:00 pm ET.